Artiva Biotherapeutics, Inc. (ARTV)
7.29
+0.49
(+7.21%)
USD |
NASDAQ |
Jun 09, 14:12
Artiva Biotherapeutics EPS Diluted (Quarterly) : -0.9529 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
| Anixa Biosciences, Inc. | -0.0772 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.52M |
| Total Expenses (Quarterly) | 23.52M |
| Enterprise Value | 91.55M |
| Earnings Yield | -48.69% |
| Normalized Earnings Yield | -48.69 |